Camelid News and Research

RSS

Avian influenza A H5N1 virus impacts wide range of wildlife in the U.S., study shows

Study highlights the spread of the highly pathogenic avian influenza A (H5N1) virus among non-domesticated animals in the U.S., revealing neurological symptoms as a key clinical presentation and expanding the range of species affected by this Eurasian lineage virus.

19 Nov 2023

The power of nanobodies: How they impact COVID-19 immune response

The structures of 340 antibodies (Abs) and 83 nanobodies.

25 Sep 2023

Study uncovers a novel fold within the SARS-CoV-2 replication co-factor non-structural protein 9

Researchers present the crystal structure of an anti-non-structural protein 9 specific nanobody in complex with the SARS-CoV-2 nsp9.

15 Apr 2023

Yeast display used to generate SARS-CoV-2 RBD-specific nanobodies

Researchers engineered biparatopic nanobodies against SARS-CoV-2.

5 Oct 2022

The potential of nanobody engineering in the development of SARS-CoV-2 antivirals and diagnostic tools

Researchers investigated nanobody engineering to develop antivirals and diagnostic tools against SARS-CoV-2.

20 Sep 2022

Immune particles from llama blood could offer protection against several COVID-19 variants

Mount Sinai-led researchers have shown that tiny, robust immune particles derived from the blood of a llama could provide strong protection against every COVID-19 variant, including Omicron, and 18 similar viruses including SARS-CoV-2 and SARS-CoV-1, which was responsible for the 2003 SARS outbreak.

29 Jun 2022

Super-immunity in a camelid extensively immunized with the SARS-CoV-2 receptor-binding domain

A recent study published in Cell Reports reported the development of pan-sarbecovirus nanobodies (psNbs).

10 Jun 2022

Tiny shark-derived antibodies broadly neutralize most SARS-CoV-2 variants

Resarchers discuss the ability of shark-derived antibodies to protect against multiple variants of SARS-CoV-2.

23 May 2022

Camelid IFNs could play important role in combating emerging zoonotic pathogens

In a recent study published in the Developmental & Comparative Immunology journal, the discovery of a novel form of mammalian interferon-Beta (IFN-β) with four cysteine residues from the dromedary camel and the five remaining members of the mammalian suborder Tylopoda is described.

17 May 2022

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

Researchers evaluate antiviral effects of CD63 tetraspanin extracellular vesicles against SARS-CoV-2 and HIV-1.

22 Mar 2022

Inhalable antibody fragments offer broad protection from SARS-CoV-2 variants

A new study describes a potential new approach to treating COVID-19 in the form of single-chain fragment variable (scFv) antibodies.

20 Feb 2022

How to achieve fast, accurate and reliable quantitation of AAV serotypes

In this interview, News-Medical talks to Indrani Chakraborty from GatorBio about how they have achieved accurate and reliable quantitation of AAV serotypes.

From Gator Bio, Inc. 19 Nov 2021

SARS-CoV-2 variants neutralized by camel nanobodies

Researchers from the US recently isolated two VHH nanobodies - 7A3 and 8A2 - from dromedary camels (Camelus dromedaries) using phage display. These nanobodies were found to have a high affinity for the spike RBD and broad neutralization abilities against SARS-CoV-2 and its variants.

2 Nov 2021

Camelid News and Research

Avian influenza A H5N1 virus impacts wide range of wildlife in the U.S., study shows

The power of nanobodies: How they impact COVID-19 immune response

Study uncovers a novel fold within the SARS-CoV-2 replication co-factor non-structural protein 9

Yeast display used to generate SARS-CoV-2 RBD-specific nanobodies

The potential of nanobody engineering in the development of SARS-CoV-2 antivirals and diagnostic tools

Immune particles from llama blood could offer protection against several COVID-19 variants

Super-immunity in a camelid extensively immunized with the SARS-CoV-2 receptor-binding domain

Tiny shark-derived antibodies broadly neutralize most SARS-CoV-2 variants

Camelid IFNs could play important role in combating emerging zoonotic pathogens

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

Inhalable antibody fragments offer broad protection from SARS-CoV-2 variants

How to achieve fast, accurate and reliable quantitation of AAV serotypes

SARS-CoV-2 variants neutralized by camel nanobodies

The neutralization potential of nanobodies against SARS-CoV-2

Nasal delivery of single-domain antibodies improves SARS-CoV-2 symptoms in animal model

Aptamer Group and Bio-Works Technologies partner to enable improved solutions for gene therapy manufacturing

Camelid nanobody anti-SARS-CoV-2 drug candidates

Researchers discover camelid-derived two nanobodies that target SARS-CoV-2

Llama ‘nanobodies’ have the potential to outwit human cytomegalovirus

Engineering nanobodies to fight against the SARS-CoV-2 virus

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News